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Abstract 
Resolution of erythro-7-hydroxy-3′,5′-dimethoxy-3,4-methylenedioxy-8.4′-oxyneolign-8′-ene 1c 
was achieved by preparing the diastereomeric esters with (–)-(R)-α-methoxyphenylacetic acid. 
The correlation of its CD properties with the absolute configuration established a general CD 
method for the configurational assignment of erythro-8.4′-oxyneolignenes: positive Cotton 
effects of the two low-energy CD transitions derive from 7R,8S configuration while the negative 
ones from 7S,8R. This rule allows the configurational assignment of erythro-8.4′-oxyneolignenes 
with different aromatic substitution pattern by a CD measurement. 
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Introduction 
 
Within the great structural variety of neolignans, the 8.O.4′-type represents a small subgroup 
whose members were isolated exclusively from the plants of Myristicaceae species and studied 
for a wide range of biological activities such as antifungal,1,2 antileukemic,3 anti-leishmanial,4 
and antioxidant activity.5,6 While the erythro and threo-isomers of 8.4′-oxyneolign-8′-enes were 
found to exhibit significantly different activities in pharmacological assays,1,5,6 the differences in 
the activities of the enantiomers of the erythro or threo series have not been studied yet.  
The absolute configurations of erythro-8.4′-oxyneolign-8′-enes were determined by 
Horeau’s7,8 and Mosher’s8,9 methods or on the basis of the transition state of the asymmetric 
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reduction if an enantioselective synthesis was achieved.7,8 Although the optical properties of 
these erythro-neolignenes were characterized by their optical rotation, these data can not be used 
for direct comparison if the substitution patterns of the aromatic rings are different or a glycoside 
residue is present. Thus, if the absolute configurations of erythro-8.4′-oxyneolign-8′-enes of 
natural origin are to be determined, a derivatization by Mosher’s or Horeau’s methods needs to 
be carried out in each case. This drawback can be the main reason that the absolute 
configurations of several recently isolated optically active erythro-8.4′-oxyneolign-8′-enes have 
not been determined.10–12 For the configurational assignment of these compounds a circular 
dichroism (CD) spectroscopic method is required which can be generally applied regardless of 
the substitution pattern of the aromatic rings and the presence of a sugar moiety or acetate group.  
Recently, effective enantiomeric separations of rac-erythro-8.4′-oxyneolign-8′-enes 1a–g with 
different aromatic substitution pattern were achieved on a Chiralcel OD column which allowed 
the LC/CD analysis of the enantiomers.13 These LC/CD data revealed that the different 
substitution patterns of the rings A and B induce only wavelength shifts in the CD spectra of the 
first eluted enantiomers while the two low-energy CD transitions were always negative. On the 
basis of Arnoldi and Merlini’s CD results,14 the 7S,8R absolute configuration was proposed for 
the first eluted enantiomers. This assignment suggested the revision of configuration of formerly 
isolated erythro-8.4′-oxyneolign-8′-enes15 and allowed the determination of configuration in 
others with CD data reported.16,17 The configurational assignments of the erythro-8.4′-
oxyneolign-8′-enes 1a–g rely on the comparison with Arnoldi and Merlini’s CD results.14 In 
order to confirm our assignment independently and to establish a general CD method, the natural 
product rac-1c was chosen for resolution to determine the configuration of its enantiomers by 
Mosher’s method. Then the comparison of the CD spectrum measured for the optically active 1c 
with the on-line LC/CD spectra of 1a–g would enable their independent configurational 
assignments, and the optical rotation of 1c can be correlated with its CD data as well. 
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Results and Discussion 
 
The erythro-8.4′-oxyneolign-8′-ene 1c, isolated from the seeds of Myristica fragrans Houtt. 
(nutmeg) by Forrest et al.,18 was obtained in racemic form according to a known procedure.6 
Racemic (±)-1c was converted with (R)-(–)- α-methoxyphenylacetic acid [(R)-(–)-MPA] into the 
diastereomeric esters (7R,8S)-(–)-3c and (7S,8R)-(–)-3c which could be separated by flash 
chromatography (Scheme 1). While the Mosher method19 is usually applied in a manner that the 
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(R)- and (S)-MPA esters of a given secondary alcohol are prepared for the determination of its 
configuration, in this case the (R)-MPA esters of two enantiomeric neolignenes were prepared to 
gain the same information.  
In the low-energy conformer19 of (7R,8S)-(–)-3c the side with ring B is shielded by the 
phenyl group of (R)-MPA, while in (7S,8R)-(–)-3c ring A is shielded (Figure 1). 
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Scheme 1. Resolution of (±)-1c with (R)-(–)-MPA: methoxy(phenyl)acetic acid. EDC: N-[3-
(dimethylamino)propyl]-N′-ethylcarbodiimide hydrochloride, DMAP: 4-dimethylaminopyridine. 
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Figure 1. Low-energy conformers of esters (7R,8S)-(–)-3c and (7S,8R)-(–)-3c indicating the 
shielding effect of the MPA phenyl ring. 
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As a result, the substraction of corresponding proton and carbon signals of (7S,8R)-(–)-3c 
from those of (7R,8S)-(–)-3c resulted in negative ∆δ values for side B and positive ones for side 
A, which allowed the configurational assignment of (7R,8S)-(–)-3c and (7S,8R)-(–)-3c (Table 1). 
The proton signals of H-8 and the carbon signals of C-9, C-2′ and C-6′ showed discrepancies, 
which are likely due to the effect of the methoxy oxygens or experimental error of the NMR 
measurement. The ester (7R,8S)-(–)-3c was hydrolyzed with 1N NaOMe in anhydrous methanol 
to give (7R,8S)-(–)-1c; its CD spectrum has two positive maxima above 230 nm in acetonitrile 
[246 (2.22), 280 (0.46)]. These CD bands have opposite signs and much lower intensities 
compared to those obtained from the LC/CD measurement of the first eluted enantiomer of 1c 
[n-hexane/2-propanol 9:1; 246 (–8.35), 281 (–1.35)];13 its absolute configuration 7S,8R was 
proposed on the basis of Arnoldi and Merlini’s CD results.14  
 
Table 1. Selected 1H and 13C NMR (in italics) data of (7R,8S)-(–)-3c, (7S,8R)-(–)-3c, and 
chemical shift differences. Side A refers to ring A and side B refers to side chain atoms 8, 9 with 
ring B, both sides flanking the stereogenic center C-7 
Side A Side B 
2 5 6 10 OMe 8 9 7′ 9′ 2′ 6′ 
(7R,8S)-
(–)-3c 
6,81 
107,58 
6,70 
107,78 
6,68 
120,62 
5,90 
100,87 
3,67 
55,85 
4,30 
80,02 
1,12 
14,68 
3,29 
40,44 
5,05 
115,82 
6,33 
105,60 
6,33 
105,60 
(7S,8R)-
(–)-3c 
6,16 
106,64 
6,47 
107,70 
6,15 
119,35 
5,38 
100,82 
3,79 
55,98 
4,25 
80,61 
1,21 
13,80 
3,33 
40,50 
5,08 
115,94 
6,40 
105,52 
6,40 
105,52 
∆δ 0,65 
0,94 
0,23 
0,09 
0,53 
1,27 
0,52 
0,05 
–0,12 
–0,12 
0,05 
–0,59 
–0,09 
0,88 
–0,04 
–0,06 
–0,03 
–0,12 
–0,07 
0,08 
–0,07 
0,08 
 
The opposite CD signs unambiguously confirm the previously proposed configurational 
assignments of the erythro-8.4′-oxyneolign-8′-enes 1a–g based on Arnoldi and Merlini’s CD 
result14 as correct, and hence they can be used as reference. Moreover, the negative specific 
rotation of (7R,8S)-1c, [ ]α D20  –16.1, (CHCl3; c = 0.26), is in agreement with Zacchino and 
Badano’s result,8 who have reported the 7R,8S configuration for (–)-1c, [ ]α D20  –27, ee = 80% 
(CHCl3; c = 1), but did not disclose any CD data. Both the lower CD intensities and the lower 
specific rotation of (–)-(7R,8S)-1c obtained by hydrolysis suggest that racemization may have 
occurred in the course of the hydrolysis of ester (7R,8S)-(–)-3c. Thus the product of the 
hydrolysis was studied by HPLC (Chiralcel OD, n-hexane/2-propanol 9:1) which proved that  
(7R,8S)-(–)-1c was partially racemized to (7S,8R)-(+)-1c during the hydrolysis which reduced 
the enantiomeric excess to 50% according to HPLC evidence. The inversion must have taken 
place on both stereogenic centers because the presence of threo-8.4′-oxyneolign-8′-ene was not 
detected.  
The correlation of the absolute configuration of (7R,8S)-(–)-1c with its positive CD 
transitions at 246 and 280 nm unambiguously proved that the first eluted isomers of the erythro-
8.4′-oxyneolign-8′-enes 1a-g (Chiralcel OD column), showing negative Cotton effects (CEs) for 
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the two low-energy CD transitions (second and third columns in Table 2), have the 7S,8R 
absolute configuration. In contrast to the optical rotation, the signs of these characteristic CD 
transitions are not sensitive to the substitution pattern of the aromatic rings which is exemplified 
by the LC/CD data of 1a–g showing only wavelength shifts depending on the nature of the 
substituents.  
Thus the absolute configurations of the isolated erythro-8.4′-oxyneolign-8′-enes can be 
deduced from a CD measurement; positive CEs of the two low-energy CD transitions derive 
from 7R,8S configuration while the negative ones from 7S,8R. 
 
Table 2. CD data of first eluted erythro-(7S,8R)- 8.4′-oxyneolign-8′-enes 1a–g obtained by 
LC/CD measurement (Chiralcel OD column) 
Compound CD Data in n-hexane/propan-2-ol (9:1) [nm (∆ε)] 
1a 280 (–1.08)sh, 275 (–1.13), 265 (–0.88) 244 (–10.43) 229 (1.95) 
1b 278 (–1.27), 270 (–1.30) 243 (–10.58) 230 (2.21) 
1c 296 (–0.59)sh, 290 (–0.87)sh, 281 (–1.35) 246 (–8.35) 217 (–1.55) 
1d 278 (–1.78) 239 (–9.52) 226 (0.39), 216 (–1.63)sh, 
209 (–7.19) 
1e 294 (–0.60)sh, 283 (–1.71) 239 (–6.79) 224 (–1.95)sh 
1f 310 (–1.07)sh, 299 (2.15)sh, 289 (–2.38) 255 (–6.03) 234 (6.20) 
1g 312 (–0.67)sh, 294 (–1.78), 277 (–1.93)sh 263 (5.00)sh 
256 (–6.35) 
235 (5.21) 
 
 
Experimental Section 
 
General Procedures. Column chromatography was performed on silica gel (Merck 60, 70–230 
mesh). The thin layer chromatography was performed on aluminum backed TLC plates of silica 
gel 60 F254 (Merck, 0.2 mm) with the indicated eluent. The HPLC was performed on Chiralcel 
OD column (250x4.6 mm, 10 µm, analytical column, Daicel Chemical Industries, LTD.) with 
Jasco type HPLC system: Jasco PU-980 HPLC Pump, Jasco MD-910 Multiwavelength detector. 
NMR spectra were recorded on a Bruker AM 360 (360.13 MHz for 1H, 90.03 MHz for 13C) 
spectrometer. Chemical shifts (δ) are given from internal CHCl3 (7.26) for 
1H NMR, 13CDCl3 
(77.0). Coupling constants (J in Hz) are accurate to ±0.2 Hz for 1H. CD spectra were obtained 
with a Jasco-810 spectropolarimeter in Sharlau Spectosolv grade solvents at room temperature. 
(±)-erythro-7-Hydroxy-3′,5′dimethoxy-3,4-methylenedioxy-8.4′-oxyneolign-8′-ene [(±)-1c] was 
prepared according to the literature.6 
 
(R)-MPA Esters of (7R,8S)-(–)-erythro-7-hydroxy-3′,5′-dimethoxy-3,4-methylenedioxy-8.4′-
oxyneolign-8′-ene [(7R,8S)-(–)-3c] and (7S,8R)-(–)-erythro-7-hydroxy-3′,5′-dimethoxy-3,4-
methylenedioxy-8.4′-oxyneolign-8′-ene [(7S,8R)-(–)-3c]. To a magnetically stirred solution of 
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R-(–)-MPA (64 mg, 0.39 mmol), N-[3-(dimethylamino)propyl]-N′-ethylcarbodiimide hydro-
chloride (EDC) (74 mg, 0.39 mmol), and 4-dimethylaminopyridine (DMAP) (8 mg, 0.07 mmol) 
in anhydrous dichloromethane (5 mL), a solution of (±)-1c (49 mg, 0.13 mmol) in anhydrous 
dichloromethane (2 mL) was slowly added. The reaction mixture was stirred at room temperature 
for 24 h, and was then evaporated to dryness under reduced pressure. The residue was purified 
by flash chromatography (hexane/EtOAc 6:1) to afford (7R,8S)-(–)-3c (30 mg, 45%) as an oil 
and (7S,8R)-(–)-3c (25 mg, 37%) as white crystals, mp 107–108 °C. 
(R)-MPA Ester of (7R,8S)-(–)-3c. [ ]α D20  –7.5 (CHCl3; c = 0.60), CD (CH3CN, 0.20 mM), λ 
(∆ε): 282 (0.27), 246 (1.26), 226 (–2.81) nm. 1H NMR (360.13 MHz, CDCl3): δ 7.49 (2H, d, J = 
7.2 Hz, H-12, H-16), 7.33 (3H, m, J = 7.2 Hz, H-13, H-14, H-15), 6.81 (1H, s, H-2), 6.70 (1H, d, 
J = 3.6 Hz, H-5), 6.68 (1H, d, J = 3.6 Hz, H-6), 6.33 (2H, s, H-2′, H-6′), 5.97 (1H, m, H-8′), 5.90 
(2H, s, H-10), 5.08 (2H, m, J = 9.7 Hz, H-9′), 4.84 (1H, s, α-H(MPA)), 4.29 (1H, m, J = 4.6 Hz H-
8), 3.67 (3H, s, OMe), 3.48 (3H, s, OMe), 3.31 (1H?, d, J = 6.5 Hz, H-7’), 1.14 (3H, d, J = 6.1 
Hz, H-9). 13C NMR (90.03 MHz, CDCl3): δ 169.7 (C=O), 153.3 (C-3′, C-5′), 147.4 (C-3), 147.0 
(C-4), 137.2 (C-8′), 136.3 (C-4′), 135.6 (C-1), 134.0 (C-1′), 131.6 (C-11), 128.4 (C-12, C-16), 
127.1 (C-13, C-14, C-15), 120.6 (C-6), 115.8 (C-9′), 107.8 (C-5), 107.6 (C-2), 105.6 (C-2′, C-6′), 
100.9 (C-10), 82.9 (CHMPA), 80.0 (C-8), 77.8 (C-7), 57.5 (OMeMPA), 55.9 (OMe), 40.4  (C-7′), 
14.7 (C-9). 
(R)-MPA Ester of (7S,8R)-(–)-3c. [ ]α D20  –67.40 (CHCl3; c = 0.50), CD (CH3CN, 0.35 mM), λ 
(∆ε): 281 (-0.51), 246 (-2.36), 225 (-7.19) nm. 1H NMR (360.13 MHz, CDCl3): δ 7.46 (2H, d, J 
= 7.2 Hz, H-12, H-16), 7.39 (3H, J = 7.2 Hz, H-13, H-14, H-15), 6.48 (1H, d, J = 3.6 Hz, H-5), 
6.40 (2H, s, H-2′, H-6), 6.16 (1H, s, H-2), 6.14 (1H, d, J = 3.6 Hz, H-6), 5.98 (1H, m, H-8′), 5.83 
(2H, s, H-10), 5.08 (2H, m, J = 9.7 Hz, H-9′), 5.01 (1H, s, α-H(MPA)), 4.25 (1H, m, J = 4.6 Hz, H-
8), 3.79 (3H, s, OMe), 3.41 (3H, s, OMe), 3.34 (2H, d, J = 6.5 Hz, H-7′), 1.22 (3H, d, J = 6.1 Hz, 
H-9). 13C NMR (90.03 MHz, CDCl3): δ 169.2 (C=O), 153.3 (C-3′, C-5′), 146.7 (C-3, C-4), 137.2 
(C-8′), 136.4 (C-4′), 136.0 (C-1), 133.7 (C-1′), 131.3 (C-11), 128.7 (C-12, C-16), 128.6 (C-13, C-
14, C-15), 119.4 (C-6), 115.9 (C-9′), 107.7 (C-5), 106.6 (C-2), 105.5 (C-2′, C-6′), 100.8 (C-10), 
82.2 (CH-MPA), 80.6 (C-8), 76.7 (C-7), 56.9 (OMe-MPA), 55.9 (OMe), 40.5 (C-7′), 13.8 (C-9). 
(7R,8S)-(–)-7-Hydroxy-3′,5′-dimethoxy-3,4-methylenedioxy-8.4′-oxyneolign-8′-ene [(7R,8S)-
(–)-1c]. To a magnetically stirred solution of (7R,8S)-(–)-3c (30 mg, 0.06 mmol) in anhydrous 
MeOH (5 mL) was added 1N NaOMe solution (5 drops) at room temperature. After 24 h, the 
reaction mixture was evaporated to dryness under reduced pressure, and the residue was purified 
by preparative TLC (hexane/EtOAc 4:1) to give (7R,8S)-(–)-1c as a colorless oil (13 mg, 59%). 
[ ]α D20  = –16.1 (CHCl3; c 0.26). CD (CH3CN, 0.35 mM): λ (∆ε) 246 (2.22), 280 (0.46), 292sh 
(0.25), 296sh (0.18) nm. 1H NMR (CDCl3): δ 6.86 (1H, s, H-2), 6.74 (2H, s, H-5, H-6), 6.45 (2H, 
s, H-2′, H-6′), 6.02 (1H, m, H-8′), 5.92 (2H, s, H-10), 5.08 (2H, m, J = 9.7 Hz, H-9), 4.76 (1H, s, 
H-7), 4.31 (1H, m, J = 4.6 Hz, H-8), 3.86 (6H, s, 2xOMe), 3.35 (2H, d, J = 6.7 Hz, H-7′), 1.13 
(3H, d, J = 4.1 Hz, H-9). 
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